PETQ Live signals | Maximize Profits with Getagraph.com

SELL 104957 min ago

@ $17.87

Issued: 13 Feb 2024 @ 15:58

Return: -8.03%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: -1.05 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 14:13):

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services...

Stats
Today's Volume	52 526.00
Average Volume	305 993
Market Cap	484.56M
EPS	$0 ( 2024-02-28 )
Next earnings date	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	234.79
ATR14	$0.0160 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-12	Christensen Mccord	Buy	5 680	Class A Common Stock
2024-03-12	Christensen Mccord	Sell	2 236	Class A Common Stock
2024-03-12	Christensen Mccord	Sell	5 680	Restricted Stock Unit
2024-03-12	Smith Michael A	Buy	1 581	Class A Common Stock
2024-03-12	Smith Michael A	Sell	714	Class A Common Stock

INSIDER POWER
49.85
Last 99 transactions
Buy: 1 116 608 \| Sell: 323 106

Volume Correlation

Long: -0.15 (neutral)

Short: 0.26 (neutral)

Signal:(60.216) Neutral

PetIQ Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PetIQ Inc Correlation - Currency/Commodity

0.41
( neutral )

0.34
( neutral )

0.00
( neutral )

0.40
( neutral )

0.00
( neutral )

-0.42
( neutral )

PetIQ Inc Financials

Annual	2023
Revenue:	$1.10B
Gross Profit:	$252.74M (22.94 %)
EPS:	$0.0731

FY	2023
Revenue:	$1.10B
Gross Profit:	$252.74M (22.94 %)
EPS:	$0.0731

FY	2022
Revenue:	$921.51M
Gross Profit:	$209.66M (22.75 %)
EPS:	$-1.670

FY	2021
Revenue:	$932.53M
Gross Profit:	$186.39M (19.99 %)
EPS:	$-0.570

Financial Reports:

No articles found.

PetIQ Inc

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.